These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 21596749)

  • 21. Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread.
    Laquerre S; Argnani R; Anderson DB; Zucchini S; Manservigi R; Glorioso JC
    J Virol; 1998 Jul; 72(7):6119-30. PubMed ID: 9621076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diversity of heparan sulfate and HSV entry: basic understanding and treatment strategies.
    Tiwari V; Tarbutton MS; Shukla D
    Molecules; 2015 Feb; 20(2):2707-27. PubMed ID: 25665065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Herpes simplex virus glycoprotein B binds to cell surfaces independently of heparan sulfate and blocks virus entry.
    Bender FC; Whitbeck JC; Lou H; Cohen GH; Eisenberg RJ
    J Virol; 2005 Sep; 79(18):11588-97. PubMed ID: 16140736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zebrafish encoded 3-O-sulfotransferase-2 generated heparan sulfate serves as a receptor during HSV-1 entry and spread.
    Baldwin J; Antoine TE; Shukla D; Tiwari V
    Biochem Biophys Res Commun; 2013 Mar; 432(4):672-6. PubMed ID: 23416072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A boost to the antiviral activity: Cholesterol tagged peptides derived from glycoprotein B of Herpes Simplex virus type I.
    Lombardi L; Falanga A; Del Genio V; Palomba L; Galdiero M; Franci G; Galdiero S
    Int J Biol Macromol; 2020 Nov; 162():882-893. PubMed ID: 32569683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid Screening by Cell-Based Fusion Assay for Identifying Novel Antivirals of Glycoprotein B-Mediated Herpes Simplex Virus Type 1 Infection.
    Maeda N; Furukawa A; Kakita K; Anada M; Hashimoto S; Matsunaga S; Kuroki K; Ose T; Kato A; Arii J; Kawaguchi Y; Arase H; Maenaka K
    Biol Pharm Bull; 2016; 39(11):1897-1902. PubMed ID: 27803463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural and functional features of the polycationic peptide required for inhibition of herpes simplex virus invasion of cells.
    Trybala E; Olofsson S; Mårdberg K; Svennerholm B; Umemoto K; Glorioso JC; Bergström T
    Antiviral Res; 2004 Jun; 62(3):125-34. PubMed ID: 15130536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zebrafish-encoded 3-O-sulfotransferase-3 isoform mediates herpes simplex virus type 1 entry and spread.
    Hubbard S; Darmani NA; Thrush GR; Dey D; Burnham L; Thompson JM; Jones K; Tiwari V
    Zebrafish; 2010 Jun; 7(2):181-7. PubMed ID: 20441522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro antiviral activity of neem (Azardirachta indica L.) bark extract against herpes simplex virus type-1 infection.
    Tiwari V; Darmani NA; Yue BY; Shukla D
    Phytother Res; 2010 Aug; 24(8):1132-40. PubMed ID: 20041417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.
    Akkarawongsa R; Pocaro NE; Case G; Kolb AW; Brandt CR
    Antimicrob Agents Chemother; 2009 Mar; 53(3):987-96. PubMed ID: 19104014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel glycoprotein D-specific monoclonal antibody neutralizes herpes simplex virus.
    Du R; Wang L; Xu H; Wang Z; Zhang T; Wang M; Ning Y; Deng F; Hu Z; Wang H; Li Y
    Antiviral Res; 2017 Nov; 147():131-141. PubMed ID: 29061442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive analysis of herpes simplex virus 1 (HSV-1) entry mediated by zebrafish 3-O-Sulfotransferase isoforms: implications for the development of a zebrafish model of HSV-1 infection.
    Yakoub AM; Rawal N; Maus E; Baldwin J; Shukla D; Tiwari V
    J Virol; 2014 Nov; 88(21):12915-22. PubMed ID: 25142596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HVEM and nectin-1 are the major mediators of herpes simplex virus 1 (HSV-1) entry into human conjunctival epithelium.
    Akhtar J; Tiwari V; Oh MJ; Kovacs M; Jani A; Kovacs SK; Valyi-Nagy T; Shukla D
    Invest Ophthalmol Vis Sci; 2008 Sep; 49(9):4026-35. PubMed ID: 18502984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double mutation in glycoprotein gB compensates for ineffective gD-dependent initiation of herpes simplex virus type 1 infection.
    Uchida H; Chan J; Goins WF; Grandi P; Kumagai I; Cohen JB; Glorioso JC
    J Virol; 2010 Dec; 84(23):12200-9. PubMed ID: 20861246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A sugar binding protein cyanovirin-N blocks herpes simplex virus type-1 entry and cell fusion.
    Tiwari V; Shukla SY; Shukla D
    Antiviral Res; 2009 Oct; 84(1):67-75. PubMed ID: 19665490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Amino Terminus of Herpes Simplex Virus 1 Glycoprotein K (gK) Is Required for gB Binding to Akt, Release of Intracellular Calcium, and Fusion of the Viral Envelope with Plasma Membranes.
    Musarrat F; Jambunathan N; Rider PJF; Chouljenko VN; Kousoulas KG
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29321326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A role for 3-O-sulfated heparan sulfate in cell fusion induced by herpes simplex virus type 1.
    Tiwari V; Clement C; Duncan MB; Chen J; Liu J; Shukla D
    J Gen Virol; 2004 Apr; 85(Pt 4):805-809. PubMed ID: 15039523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody Screening System Using a Herpes Simplex Virus (HSV)-Based Probe To Identify a Novel Target for Receptor-Retargeted Oncolytic HSVs.
    Ikeda H; Uchida H; Okubo Y; Shibata T; Sasaki Y; Suzuki T; Hamada-Uematsu M; Hamasaki R; Okuda K; Yamaguchi M; Kojima M; Tanaka M; Hamada H; Tahara H
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33627393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Syncytial Mutations Do Not Impair the Specificity of Entry and Spread of a Glycoprotein D Receptor-Retargeted Herpes Simplex Virus.
    Okubo Y; Uchida H; Wakata A; Suzuki T; Shibata T; Ikeda H; Yamaguchi M; Cohen JB; Glorioso JC; Tagaya M; Hamada H; Tahara H
    J Virol; 2016 Dec; 90(24):11096-11105. PubMed ID: 27707922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A single-amino-acid substitution in herpes simplex virus 1 envelope glycoprotein B at a site required for binding to the paired immunoglobulin-like type 2 receptor alpha (PILRalpha) abrogates PILRalpha-dependent viral entry and reduces pathogenesis.
    Arii J; Wang J; Morimoto T; Suenaga T; Akashi H; Arase H; Kawaguchi Y
    J Virol; 2010 Oct; 84(20):10773-83. PubMed ID: 20686018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.